Browse 10 Oncology companies funded by OrbiMed. See funding amounts, founder contacts, and investment details.
Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.
ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.
BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
View all companies funded by OrbiMed across every industry and funding stage.
View Full OrbiMed Portfolio